IL162563A0 - Pharmaceutical compositions based on azetidine derivatives - Google Patents
Pharmaceutical compositions based on azetidine derivativesInfo
- Publication number
- IL162563A0 IL162563A0 IL16256302A IL16256302A IL162563A0 IL 162563 A0 IL162563 A0 IL 162563A0 IL 16256302 A IL16256302 A IL 16256302A IL 16256302 A IL16256302 A IL 16256302A IL 162563 A0 IL162563 A0 IL 162563A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions based
- azetidine derivatives
- azetidine
- derivatives
- Prior art date
Links
- 150000001539 azetidines Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0116638A FR2833842B1 (en) | 2001-12-21 | 2001-12-21 | PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES |
| PCT/FR2002/004514 WO2003053431A2 (en) | 2001-12-21 | 2002-12-20 | Pharmaceutical compositions based on azetidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162563A0 true IL162563A0 (en) | 2005-11-20 |
Family
ID=8870824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16256302A IL162563A0 (en) | 2001-12-21 | 2002-12-20 | Pharmaceutical compositions based on azetidine derivatives |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1458413B1 (en) |
| JP (1) | JP5021887B2 (en) |
| KR (1) | KR20040068308A (en) |
| CN (1) | CN100388918C (en) |
| AP (1) | AP1754A (en) |
| AR (1) | AR037687A1 (en) |
| AU (1) | AU2002364866B2 (en) |
| BR (1) | BR0215048A (en) |
| CA (1) | CA2470443A1 (en) |
| CO (1) | CO5590911A2 (en) |
| DE (1) | DE60233071D1 (en) |
| DK (1) | DK1458413T3 (en) |
| EA (1) | EA006510B1 (en) |
| EC (1) | ECSP045162A (en) |
| FR (1) | FR2833842B1 (en) |
| HR (1) | HRP20040575A2 (en) |
| HU (1) | HUP0402586A3 (en) |
| IL (1) | IL162563A0 (en) |
| MA (1) | MA27086A1 (en) |
| ME (1) | MEP16608A (en) |
| MX (1) | MXPA04005558A (en) |
| MY (1) | MY138172A (en) |
| NO (1) | NO20042781L (en) |
| NZ (1) | NZ533225A (en) |
| OA (1) | OA12750A (en) |
| PL (1) | PL203248B1 (en) |
| RS (1) | RS55504A (en) |
| TW (1) | TWI256304B (en) |
| UA (1) | UA77736C2 (en) |
| WO (1) | WO2003053431A2 (en) |
| ZA (1) | ZA200404338B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1498122A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Semi-solid systems containing azetidine derivatives |
| EP1498123A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Emulsifying systems containing azetidine derivatives |
| BRPI0507801A (en) | 2004-02-17 | 2007-07-10 | Esteve Labor Dr | substituted azetidine compounds, process for preparing substituted azetidine compounds, medicament and use of at least one substituted azetidine compound |
| FR2879932B1 (en) * | 2004-12-27 | 2007-03-23 | Aventis Pharma Sa | FORMULATIONS INJECTABLE OR ORALLY ADMINISTRATIVE OF AZETIDINE DERIVATIVES |
| MX2007016508A (en) | 2005-06-30 | 2008-03-04 | Prosidion Ltd | Gpcr agonists. |
| CL2008000017A1 (en) | 2007-01-04 | 2008-08-01 | Prosidion Ltd | COMPOUNDS DERIVED FROM NITROGEN AND OXYGEN HETEROCICLES, GPCR AGONISTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF OBESITY, DIABETES, METABOLIC SYNDROME, HYPERLIPIDEMIA, TOLERANCE |
| AR064735A1 (en) | 2007-01-04 | 2009-04-22 | Prosidion Ltd | GPCR AGONISTS AND PHARMACEUTICAL COMPOSITION BASED ON THE COMPOUND |
| BRPI0806312A2 (en) | 2007-01-04 | 2011-09-06 | Prosidion Ltd | cgpr piperidine agonists |
| GB0700122D0 (en) | 2007-01-04 | 2007-02-14 | Prosidion Ltd | GPCR agonists |
| JP2010514828A (en) | 2007-01-04 | 2010-05-06 | プロシディオン・リミテッド | Piperidine GPCR agonist |
| GB0720390D0 (en) | 2007-10-18 | 2007-11-28 | Prosidion Ltd | G-Protein coupled receptor agonists |
| GB0720389D0 (en) | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
| FR2923719B1 (en) * | 2007-11-15 | 2009-11-20 | Sanofi Aventis | PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES |
| FR2928149B1 (en) | 2008-02-29 | 2011-01-14 | Sanofi Aventis | AZETIDINE-DERIVED COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| FR2946650B1 (en) * | 2009-06-16 | 2011-08-19 | Sanofi Aventis | ESTERS DERIVED FROM AZETIDINES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS. |
| UA153183U (en) | 2022-10-27 | 2023-05-31 | Андрій Валерійович Максимов | GLASS FOR DRINK PREPARATION |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR73668B (en) * | 1978-11-21 | 1984-03-28 | Hoffmann La Roche | |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| HRP980026A2 (en) * | 1998-01-20 | 1999-10-31 | Pliva Pharm & Chem Works | 1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof |
| AU4989299A (en) * | 1998-07-14 | 2000-02-07 | Em Industries, Inc. | Microdisperse drug delivery systems |
| FR2783246B1 (en) * | 1998-09-11 | 2000-11-17 | Aventis Pharma Sa | AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE MEDICINES CONTAINING THEM |
| FR2805818B1 (en) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2805810B1 (en) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | PHARMACEUTICAL COMPOSITIONS CONTAINING 3- AMINO-AZETIDINE DERIVATIVES, THE NEW DERIVATIVES AND THEIR PREPARATION |
| FR2805817B1 (en) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION |
| FR2814678B1 (en) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | COMBINATION OF AN ANTAGONIST OF THE CB1 RECEPTOR AND SIBUTRAMINE, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF OBESITY |
-
2001
- 2001-12-21 FR FR0116638A patent/FR2833842B1/en not_active Expired - Fee Related
-
2002
- 2002-12-02 AR ARP020104646A patent/AR037687A1/en unknown
- 2002-12-03 TW TW091135077A patent/TWI256304B/en active
- 2002-12-20 JP JP2003554188A patent/JP5021887B2/en not_active Expired - Fee Related
- 2002-12-20 ME MEP-166/08A patent/MEP16608A/en unknown
- 2002-12-20 BR BR0215048-4A patent/BR0215048A/en not_active IP Right Cessation
- 2002-12-20 CN CNB028248406A patent/CN100388918C/en not_active Expired - Fee Related
- 2002-12-20 WO PCT/FR2002/004514 patent/WO2003053431A2/en not_active Ceased
- 2002-12-20 MX MXPA04005558A patent/MXPA04005558A/en active IP Right Grant
- 2002-12-20 DE DE60233071T patent/DE60233071D1/en not_active Expired - Lifetime
- 2002-12-20 UA UA20040706001A patent/UA77736C2/en unknown
- 2002-12-20 OA OA1200400178A patent/OA12750A/en unknown
- 2002-12-20 AU AU2002364866A patent/AU2002364866B2/en not_active Ceased
- 2002-12-20 NZ NZ533225A patent/NZ533225A/en not_active IP Right Cessation
- 2002-12-20 MY MYPI20024828A patent/MY138172A/en unknown
- 2002-12-20 EP EP02801165A patent/EP1458413B1/en not_active Expired - Lifetime
- 2002-12-20 EA EA200400843A patent/EA006510B1/en not_active IP Right Cessation
- 2002-12-20 RS YUP-555/04A patent/RS55504A/en unknown
- 2002-12-20 PL PL372708A patent/PL203248B1/en not_active IP Right Cessation
- 2002-12-20 HU HU0402586A patent/HUP0402586A3/en unknown
- 2002-12-20 IL IL16256302A patent/IL162563A0/en unknown
- 2002-12-20 DK DK02801165T patent/DK1458413T3/en active
- 2002-12-20 AP APAP/P/2004/003066A patent/AP1754A/en active
- 2002-12-20 KR KR10-2004-7009708A patent/KR20040068308A/en not_active Ceased
- 2002-12-20 CA CA002470443A patent/CA2470443A1/en not_active Abandoned
- 2002-12-20 HR HR20040575A patent/HRP20040575A2/en not_active Application Discontinuation
-
2004
- 2004-05-21 MA MA27694A patent/MA27086A1/en unknown
- 2004-06-02 ZA ZA200404338A patent/ZA200404338B/en unknown
- 2004-06-17 CO CO04056913A patent/CO5590911A2/en not_active Application Discontinuation
- 2004-06-18 EC EC2004005162A patent/ECSP045162A/en unknown
- 2004-07-01 NO NO20042781A patent/NO20042781L/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2389530B (en) | Pharmaceutical compositions | |
| GB0111597D0 (en) | Pharmaceutical compositions | |
| EP1450824A4 (en) | Pharmaceutical composition | |
| GB2391473B (en) | Pharmaceutical compositions | |
| HUP0303163A3 (en) | Tramadol-based pharmaceutical composition | |
| HUP0400850A3 (en) | Oral pharmaceutical compositions | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| GB0117057D0 (en) | Pharmaceutical composition | |
| GB0129117D0 (en) | Pharmaceutical composition | |
| IL162563A0 (en) | Pharmaceutical compositions based on azetidine derivatives | |
| GB0104752D0 (en) | Pharmaceutical compositions | |
| GB0116107D0 (en) | Pharmaceutical composition | |
| GB0213481D0 (en) | Pharmaceutical compositions | |
| GB0127805D0 (en) | Pharmaceutical composition | |
| PL370037A1 (en) | Pharmaceutical composition | |
| EP1480649A4 (en) | Stable pharmaceutical compositions | |
| GB2382302B (en) | Pharmaceutical compositions | |
| PL370907A1 (en) | Pharmaceutical compositions | |
| IL157411A0 (en) | Pharmaceutical composition | |
| GB0126732D0 (en) | Pharmaceutical compositions | |
| GB0125061D0 (en) | Pharmaceutical composition | |
| HU0103049D0 (en) | Pharmaceutical composition | |
| GB0101743D0 (en) | pharmaceutical compositions | |
| GB0121826D0 (en) | Pharmaceutical compositions | |
| GB0101744D0 (en) | Pharmaceutical compositions |